ADGMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Adagio Medical Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.12+0.02 (+21.21%)
Close on Oct 19, 2026
- Market cap
- $2.67M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.2550 (−91.27%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Adagio Medical Holdings, Inc. reported revenue of $0 for the twelve months to Jun 30, 2026. Free cash flow was -$16.57M.
Revenue
$0
TTM Q2 2026
Operating income
-$19.82M
TTM Q2 2026
Free cash flow
-$16.57M
TTM Q2 2026
EPS, diluted
-$1.43
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.67M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -621.70%
Fundamentals
- Revenue
- $0
- Net income
- -$27.14M
- EPS, diluted
- -$1.43
- Free cash flow
- -$16.57M
- Book value per share
- -$0.02
- Diluted shares
- 22M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
$0
Gross profit
–
Operating income
-$19.82M
Net income
-$27.14M
EPS, diluted
-$1.43
Free cash flow
-$16.57M
Reported periodTrailing twelve months